Search

Displaying results 1 - 10 of 23 in total
  1. Indication

    Gastroesophageal Junction Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0038020
    Drugs: Durvalumab
  2. Indication

    Locally Advanced Biliary Tract Cancer

    go.drugbank.com/conditions/DBCOND0046439
    Drugs: Durvalumab
  3. Indication

    Resectable Gastric Cancer

    go.drugbank.com/conditions/DBCOND0173768
    Drugs: Durvalumab
  4. Indication

    Stage 3 Locally Advanced Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0173359
    Drugs: Durvalumab
  5. Indication

    Small Cell Lung Cancer, Limited Stage

    go.drugbank.com/conditions/DBCOND0087944
    Drugs: Durvalumab
  6. Indication

    Unresectable Stage III Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0123170
    Drugs: Durvalumab
  7. Indication

    Advanced mismatch repair proficient (pMMR) endometrial cancer

    go.drugbank.com/conditions/DBCOND0168677
    Drugs: Durvalumab
  8. Indication

    Primary advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer

    go.drugbank.com/conditions/DBCOND0173198
    Drugs: Durvalumab
  9. Indication

    Recurrent mismatch repair proficient (pMMR) endometrial cancer

    go.drugbank.com/conditions/DBCOND0168678
    Drugs: Durvalumab
  10. Indication

    Unresectable, locally advanced PD-L1 positive Lung Cancer Non-Small Cell Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0127684
    Drugs: Durvalumab